Geron Corporation on Monday announced the enrolment of the first patient in a clinical trial to evaluate its human embryonic stem cell-based therapy in patients with recent spinal cord injury. The initiation of the Phase I clinical trial comes less than two months after the FDA removed a clinical hold on such therapies and is thought to represent the first publicly known use of embryonic stem cells in humans.
Reference Articles
First trial of embryonic stem cells in humans - (BBC News)
Geron tests stem cell treatment on patient - (Forbes)
Geron initiates clinical trial of human embryonic stem cell-based therapy - (Geron)
First patient treated in embryonic stem cell trial - (MSNBC)
Stem cell clinical trial aims to combat nerve damage in human tissue - (The Guardian)
Geron enrolls first patient in stem-cell treatment study - (The Wall Street Journal)
U.S. doctors begin first clinical trial of embryonic stem cells on humans - (USA Today)
**Published in "First Word"
No comments:
Post a Comment